The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
LLM 2021 | Differentiating Waldenström’s macroglobulinemia and cold agglutinin disease
Sigbjorn Berentsen, MD, PhD, Haugesund Hospital, Haugesund, Norway, discusses the differences between Waldenström’s macroglobulinemia (WM) and cold agglutinin disease (CAD). WM and CAD have similar features and were previously thought be to linked, but recent data have indicated that they are two separate diseases. Distinguishing features include the MYD88 L265P mutation, which is more prevalent in patients with CAD. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.
